KIRKLAND, QC – Merck, known as MSD outside of the United States and Canada, announced that British Columbia, Non-Insured Health Benefits (NIHB), Nova Scotia, Quebec and Veterans Affairs Canada (VAC)… Read More
“The window to shape the oral GLP-1 market is open now….” Early-stage discussions with several multinational pharmaceutical companies currently underway KELOWNA, BC – Lexaria Bioscience Corp., a global innovator in drug delivery… Read More
A new vaccine candidate targeting Campylobacter jejuni, one of the leading causes of bacterial diarrhea worldwide, has shown encouraging early results in a Phase 1 trial. The research team, led by… Read More
Getinge announced the receipt of CE mark for Cardiohelp II, the next evolution of its extracorporeal life support (ECLS) platform. Building on the legacy of Cardiohelp-i – widely recognized within… Read More
Human Organoid Data Supports the Therapeutic Rationale for INM-901 Program Ahead of Human Clinical Trials Consistent Anti-Inflammatory Effects Demonstrate Translation from Animal Models to Three-Dimensional Human Brain Tissue Systems Vancouver,… Read More
